BARRY GROVES: Open Payments
NPI 1508259862 · GREENVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 26 payments from 11 companies in 2025. Trend: 2023 $402 · 2024 $1,170 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $259 |
| Novo Nordisk Inc | 2 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| PFIZER INC. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: TAVNEOS, Wegovy, Kerendia, EVENITY, OTEZLA, LEQVIO, Auvelity, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
